Clinical trial
Pioglitazone and Losartan Provides Additional Renoprotection
NCT00364988 · Shanghai Jiao Tong University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00364988 |
|---|---|
| Title | Pioglitazone and Losartan Provides Additional Renoprotection |
| Official title | Combination Therapy With Pioglitazone and Losartan Provides Additional Renoprotection in Subjects With Type 2 Diabetic Nephropathy |
| Lead sponsor | Shanghai Jiao Tong University School of Medicine, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Type 2 Diabetes, Diabetic Nephropathy |
| Intervention type | Drug |
| Interventions | pioglitazone+losartan, losartan |
| Enrollment | 60 |
| Start date | Jan 1, 2005 |
| Primary completion | Dec 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Aug 16, 2006 |
| Last update posted | Oct 27, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: